| Literature DB >> 35052226 |
Seira Takada1,2, Yasuko Ogata1, Yoshie Yumoto1, Masaomi Ikeda3.
Abstract
This study aimed to develop an inventory for advance care planning implementation for persons with dementia in group homes and to examine the association between inventory implementation and residents' quality of dying. A nationwide cross-sectional study was conducted via questionnaires mailed from 2000 group homes in Japan, selected through stratified random sampling. Participants were managers and care planners who had provided end-of-life care for recently deceased residents. The newly developed inventory was used to assess advance care planning implementation for persons with dementia, and the Quality of Dying in Long-term Care Scale was used to evaluate quality of dying. The valid response rate was 28.5% (n = 569). The factor structure of the newly developed Advance Care Planning Practice Inventory and the association between its implementation and quality of dying were verified using factor analysis and internal consistency, and logistic regression, respectively. The composite score and the factor score of the newly developed inventory were significantly associated with quality of dying (p < 0.05). The implementation of advance care planning improves the quality of dying. These findings can be used in development of educational programs, as well as research on advance care planning for care providers.Entities:
Keywords: advance care planning; dementia; group homes; long-term care; nursing care
Year: 2021 PMID: 35052226 PMCID: PMC8774990 DOI: 10.3390/healthcare10010062
Source DB: PubMed Journal: Healthcare (Basel) ISSN: 2227-9032
Figure 1Flow chart of the study participants.
Characteristics of the facilities, managers, and care planners (N = 569).
| Variables | Frequency (%) | Mean (SD) |
|---|---|---|
| Facility | ||
| Established by | ||
| Social welfare corporations | 115 (20.2) | |
| Medical corporations | 103 (18.1) | |
| For-profit corporations | 300 (52.7) | |
| Other or no response | 51 (9.0) | |
| Number of units | ||
| 1 | 150 (26.4) | |
| 2 | 370 (65.0) | |
| 3 or more | 38 (6.7) | |
| No response | 11(1.9) | |
| Year of establishment (A.D.) | 2007.0 (6.2) | |
| Number of full-time nurses | 0.8 (2.5) | |
| Number of residents | 15.9 (6.5) | |
| Managers | ||
| Sex | ||
| Male | 229 (40.2) | |
| Female | 333 (58.5) | |
| No response | 7 (1.2) | |
| Type of work † | ||
| Care worker | 429 (75.4) | |
| Care manager | 252 (44.3) | |
| Nurse | 40 (7.0) | |
| Age (years) | 49.8 (10.5) | |
| Experience at the facility (years) | 9.8 (5.7) | |
| Experience as a manager (years) | 5.9 (4.8) | |
| Care Planners | ||
| Sex | ||
| Male | 152 (26.7) | |
| Female | 410 (72.1) | |
| No response | 7 (1.2) | |
| Type of work † | ||
| Care worker | 446 (78.4) | |
| Care manager | 410 (72.1) | |
| Nurse | 32 (5.6) | |
| Age (years) | 50.0 (10.9) | |
| Experience at the facility (years) | 8.4 (5.3) | |
| FATCOD-B-J-S score | ||
| Total | 23.1 (2.8) | |
| Sub-scale 1 | 11.4 (1.8) | |
| Sub-scale 2 | 11.7 (2.0) |
† Duplicate answers. Note: SD, Standard deviation; A.D., anno Domini; FATCOD-B-J-S, Japanese version of the Frommelt Attitudes toward Care of the Dying Scale short version. Sub-scale 1: positive attitudes toward caring for dying persons; sub-scale 2: recognition of caring for the pivot dying persons and their families.
Characteristics of the recently deceased residents (N = 569).
| Variables | Frequency (%) | Mean (SD) |
|---|---|---|
| Sex | ||
| Male | 124 (21.8) | |
| Female | 445 (78.2) | |
| FAST level at the time of death | 6.4 (1.1) | |
| 6 or less | 224 (39.4) | |
| 7 | 345 (60.6) | |
| Presence of end-of-life bonus | ||
| Yes | 359 (63.1) | |
| Length of stay in the facility (years) | 4.6 (3.8) | |
| Age at the time of death (years) | 91.4 (6.4) | |
| QOD-LTC score | ||
| Composite score | 3.3 (0.7) | |
| Sub-scale 1 | 3.9 (0.6) | |
| Sub-scale 2 | 3.3 (0.8) | |
| Sub-scale 3 | 2.7 (1.2) | |
| QOD-LTC score | ||
| High | 354 (62.2) |
Note: SD, standard deviation; FAST, functional assessment staging; QOD-LTC, quality of dying in long-term care. QOD-LTC score: individuals with scores ≤3 were categorized as “low group”, and those with scores >3 were categorized as “high group”. Sub-scale 1: personhood; sub-scale 2: preparatory tasks; sub-scale 3: Closure.
Items with ceiling effects (N = 569).
| Frequency (%) | ||||||
|---|---|---|---|---|---|---|
| No. | Items | Did Not | More or Less Did Not Implement | More or Less Implemented | Implemented | Mean (SD) |
| 23 | We asked Mr./Ms. A’s family members and other relevant parties about what Mr./Ms. wished regarding the final stage of life. | 16 (2.8) | 6 (1.1) | 80 (14.1) | 467 (82.1) | 3.8 (0.6) |
| 24 | We talked with A’s family members about Mr./Ms. A’s medical treatment/care options for the final stage of life. | 16 (2.8) | 2 (0.4) | 60 (10.5) | 491 (86.3) | 3.8 (0.6) |
| 25 | We talked with Mr./Ms. A’s family members or other relevant parties about relief and comfort care for distressing symptoms (e.g., breathlessness or discomfort from being unable to move) at the final stage of life. | 17 (3.0) | 9 (1.6) | 72 (12.7) | 472 (83.0) | 3.8 (0.6) |
| 26 | We facilitated and supported Mr./Ms. A’s discussions with their family members so that they could all reach a consensus concerning the policies and procedures regarding the final stage of life. | 26 (4.6) | 29 (5.1) | 112 (19.7) | 402 (70.7) | 3.6 (0.8) |
| 27 | In cases where family members or other relevant parties requested, staff members always accepted calls for consultation regarding the final stage of Mr./Ms. A’s life. | 13 (2.3) | 4 (0.7) | 107 (18.8) | 445 (78.2) | 3.7 (0.6) |
| 28 | After discussing Mr./Ms. A’s medical treatment/care policies with both family and staff members, we documented the details in Mr./Ms. A’s records. | 16 (2.8) | 16 (2.8) | 85 (14.9) | 452 (79.4) | 3.7 (0.7) |
| 29 | We asked family members and relevant parties whether or not there were any changes in their wishes regarding Mr./Ms. A’s medical treatment/care, as needed. | 16 (2.8) | 22 (3.9) | 109 (19.2) | 422 (74.2) | 3.7 (0.7) |
| 31 | We recorded wishes Mr./Ms. A had in relation to the kind of medical treatment/care. | 55 (9.7) | 53 (9.3) | 127 (22.3) | 334 (58.7) | 3.3 (1.0) |
| 32 | Information about Mr./Ms. A, even if it was not medical treatment/care-related, was kept in the records. | 7 (1.2) | 17 (3.0) | 139 (24.4) | 406 (71.4) | 3.7 (0.6) |
| 33 | The medical treatment/care policies for the final stage of Mr./Ms. A’s life were discussed and decided by the team at the facility. | 8 (1.4) | 22 (3.9) | 139 (24.4) | 400 (70.3) | 3.6 (0.6) |
| 34 | We shared Mr./Ms. A’s wishes regarding medical treatment/care with the relevant doctors. | 14 (2.5) | 11 (1.9) | 112 (19.7) | 432 (75.9) | 3.7 (0.6) |
| 35 | We shared Mr./Ms. A’s wishes regarding their medical treatment/care, as well as other relevant matters, with facility staff members. | 11 (1.9) | 14 (2.5) | 128 (22.5) | 416 (73.1) | 3.7 (0.6) |
| 36 | We shared Mr./Ms. A’s wishes about medical treatment/care with the long-term care insurance facilities and medical institution staff with whom we work. | 25 (4.4) | 34 (6.0) | 126 (22.1) | 384 (67.5) | 3.5 (0.8) |
| 37 | We kept a record of observations and significant changes pertaining to Mr./Ms. A. | 6 (1.1) | 4 (0.7) | 85 (14.9) | 474 (83.3) | 3.8 (0.5) |
| 38 | In making decisions about Mr./Ms. A’s medical treatment/care, as well as other matters, we took into consideration the wishes Mr./Ms. A expressed regarding the final stage of life and everyday routines. | 41 (7.2) | 61 (10.7) | 184 (32.3) | 283 (49.7) | 3.3 (0.9) |
| 39 | We took Mr./Ms. A’s quality of life into account when making decisions about medical treatment/care. | 4 (0.7) | 17 (3.0) | 193 (33.9) | 355 (62.4) | 3.6 (0.6) |
Note: SD, standard deviation. Scores range from “1. Did not implement” to “4. Implemented”. The percentages of each item are rounded to the nearest whole number, so the total of the breakdown may not add up to 100%.
Final exploratory factor analysis, Cronbach’s α, and descriptive statistics of the ACP-PI (N = 228).
| No. | Item | Factor Loading | ||
|---|---|---|---|---|
|
| ||||
| 1 | We judged from Mr./Ms. A’s words, actions, and appearance whether or not they were willing to talk about the final stage of life. |
| −0.09 | 0.15 |
| 2 | We informed Mr./Ms. A about the medical treatment/care available and how they could spend the final stage of life, as detailed within the facility’s policies. |
| −0.01 | −0.02 |
| 3 | We informed Mr./Ms. A of the significance of communicating their wishes regarding the final stage of life and everyday routines to family and the facility’s staff members while they were still able to express wishes. |
| 0.06 | −0.08 |
| 4 | We informed Mr./Ms. A of what things they should tell family and staff members while they were still able to express wishes. |
| 0.09 | −0.02 |
| 5 | We presented Mr./Ms. A with specific details about what medical treatment/care options were available as they entered the final stage of life (note: this statement includes cases where part-time doctors or similar staff presented the information). |
| 0.04 | −0.01 |
| 7 | We talked with Mr./Ms. A about what kind of medical treatment/care they wished for at the final stage of life. |
| −0.01 | −0.05 |
| 8 | We talked with Mr./Ms. A about where they would like to spend the final stages of life. |
| −0.05 | −0.06 |
| 9 | We discussed with the patient the kind of care they would like to receive to get relief and comfort from distressing symptoms (e.g., breathlessness or discomfort from being unable to move) at the final stage of life. |
| 0.00 | 0.05 |
| 10 | We discussed with Mr./Ms. A whether or not there were any changes in the their wishes regarding medical treatment/care each time it happened. |
| 0.02 | 0.07 |
| 11 | Whenever Mr./Ms. A’s condition changed, we spoke with them to establish whether or not there were any changes in wishes regarding medical treatment/care. |
| 0.04 | 0.07 |
|
| ||||
| 13 | We asked Mr./Ms. A to put their wishes regarding their medical treatment/care, as well as any other wishes, in writing. | 0.05 |
| −0.03 |
| 14 | At Mr./Ms. A’s request, we gave a copy of the written document to their spouse stating their wishes regarding medical treatment/care and other matters. | −0.06 |
| 0.01 |
| 15 | We asked Mr./Ms. A who they wished to participate in discussions about medical treatment/care and other matters relating to the time when they would no longer be able to make their own decisions. | 0.04 |
| 0.02 |
| 16 | We asked Mr./Ms. A whether or not they had informed the person they mentioned in Point 15 about their desire to have them participate in such discussions. | 0.05 |
| 0.00 |
| 17 | We informed Mr./Ms. A about representatives and/or systems that handle legal aspects after they pass away (e.g., implementing a will). | −0.04 |
| 0.02 |
|
| ||||
| 19 | We considered the topics of discussion regarding the final stage of Mr./Ms. A’s life depending on their cognitive functioning. | −0.07 | 0.02 |
|
| 20 | The ways in which I explained the final stage of life were modified depending on Mr./Ms. A’s cognitive functions. | −0.01 | −0.01 |
|
| 21 | When discussing the final stage of life with Mr./Ms. A, we checked that they understood the content. | 0.27 | 0.03 |
|
| Cronbach’s α ☨ | 0.94 | 0.86 | 0.87 | |
| Composite score, mean (SD) | 2.0 (0.7) | |||
| Factor 1, mean (SD) | 2.1 (0.8) | |||
| Factor 2, mean (SD) | 1.5 (0.7) | |||
| Factor 3, mean (SD) | 2.5 (0.9) | |||
Note: ACP, advance care planning; ACP-PI, ACP Practice Inventory; SD, standard deviation. Italics indicate factor names. Exploratory factor analysis: promax rotation, factor loading >0.45. Items with factor loadings of 0.45 or higher and belonging to a factor are expressed in bold. Bartlett’s sphericity test was significant (χ2 = 3244.2, df = 153, p < 0.01), and the Kaiser–Meyer–Olkin value was 0.92. ☨ Cronbach’s α (overall) = 0.94.
The final version of Advance Care Planning Practice Inventory (ACP-PI).
| Instruction text: Circle the Corresponding Number to Indicate Which of the Following Items Have Been Conducted in Relation to Mr./Ms. A. | |||||
|---|---|---|---|---|---|
| No. | Items | Did not | More or less Did not Implement | More or less Implemented | Implemented |
| 1 | We judged from Mr./Ms. A’s words, actions, and appearance whether or not they were willing to talk about the final stage of life. | 1 | 2 | 3 | 4 |
| 2 | We informed Mr./Ms. A about the medical treatment/care available and how they could spend the final stage of life, as detailed within the facility’s policies. | 1 | 2 | 3 | 4 |
| 3 | We informed Mr./Ms. A of the significance of communicating their wishes regarding the final stage of life and the everyday routines to the family and the facility’s staff members while they were still able to express wishes. | 1 | 2 | 3 | 4 |
| 4 | We informed Mr./Ms. A of what things they should tell family and staff members while they were still able to express wishes. | 1 | 2 | 3 | 4 |
| 5 | We presented Mr./Ms. A with specific details about what medical treatment/care options were available as they entered the final stage of life (note: this statement includes cases where part-time doctors or similar staff presented the information). | 1 | 2 | 3 | 4 |
| 6 | We talked with Mr./Ms. A about what kind of medical treatment/care they wished for at the final stage of life. | 1 | 2 | 3 | 4 |
| 7 | We talked with Mr./Ms. A about where they would like to spend the final stages of life. | 1 | 2 | 3 | 4 |
| 8 | We discussed with the patient about the kind of care they would like to receive to get relief and comfort from distressing symptoms (e.g., breathlessness or discomfort from being unable to move) at the final stage of life. | 1 | 2 | 3 | 4 |
| 9 | We discussed with Mr./Ms. A about whether or not there were any changes in the wishes of Mr./Ms. A regarding medical treatment/care, each time it happens. | 1 | 2 | 3 | 4 |
| 10 | Whenever Mr./Ms. A’s condition changed, we spoke with them to establish whether or not there were any changes in wishes regarding medical treatment/care. | 1 | 2 | 3 | 4 |
| 11 | We asked Mr./Ms. A to put their wishes regarding their medical treatment/care, as well as any other wishes, in writing. | 1 | 2 | 3 | 4 |
| 12 | At Mr./Ms. A’s request, we gave a copy of the written document to Mr./Ms. A stating the wishes regarding medical treatment/care and other matters. | 1 | 2 | 3 | 4 |
| 13 | We asked Mr./Ms. A who they wished to participate in discussions about medical treatment/care and other matters relating to the time when they would no longer be able to make their own decisions. | 1 | 2 | 3 | 4 |
| 14 | We asked Mr./Ms. A whether or not they had informed the person they mentioned in Point 17 about their desire to have them participate in such discussions. | 1 | 2 | 3 | 4 |
| 15 | We informed Mr./Ms. A about representatives and/or systems that handle legal aspects after they pass away (e.g., implementing a will). | 1 | 2 | 3 | 4 |
| 16 | We considered the topics of discussion regarding the final stage of Mr./Ms. A’s life depending on their cognitive functioning. | 1 | 2 | 3 | 4 |
| 17 | The ways in which I explained the final stage of life were modified depending on Mr./Ms. A’s cognitive functions. | 1 | 2 | 3 | 4 |
| 18 | When discussing the final stage of life with Mr./Ms. A, we checked that they understood the content. | 1 | 2 | 3 | 4 |
Logistic regression for the residents’ quality of dying and related factors (N = 569).
| Model 1 | Model 2 | Model 3 | Model 4 | Model 5 | |
|---|---|---|---|---|---|
| OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | |
| Residents’ characteristics | |||||
| Female sex † | 0.90 (0.57–1.42) | 0.97 (0.61–1.54) | 0.91 (0.58–1.42) | 0.87 (0.55–1.35) | 0.93 (0.59–1.48) |
| Length of stay (years) ‡ | 0.92 (0.54–1.55) | 0.87 (0.52–1.48) | 0.88 (0.52–1.47) | 0.95 (0.56–1.59) | 0.89 (0.53–1.51) |
| Age at death (years) | 1.05 (1.02–1.08) ** | 1.05 (1.02–1.08) ** | 1.05 (1.02–1.09) ** | 1.05 (1.02–1.08) ** | 1.05 (1.02–1.08) ** |
| FAST § | 1.10 (0.76–1.61) | 1.12 (0.76–1.63) | 1.06 (0.73–1.53) | 1.03 (0.71–1.48) | 1.12 (0.77–1.64) |
| GHPWD’s characteristics | |||||
| Number of full-time nurses | 1.13 (1.03–1.25) * | 1.13 (1.02–1.24) * | 1.12 (1.02–1.24) * | 1.13 (1.02–1.25) * | 1.13 (1.03–1.25) * |
| End-of-life care bonus ¶ | 1.64 (1.12–2.38) * | 1.69 (1.16–2.47) ** | 1.57 (1.08–2.27) * | 1.67 (1.16–2.42) ** | 1.66 (1.13–2.42) ** |
| ACP-PI | |||||
| Composite score | 2.62 (1.95–3.53) *** | ||||
| Factor 1 | 2.15 (1.70–2.73) *** | 1.75 (1.28–2.40) *** | |||
| Factor 2 | 2.16 (1.57–2.97) *** | 1.27 (0.87–1.87) | |||
| Factor 3 | 1.65 (1.35–2.01) *** | 1.17 (0.92–1.49) | |||
Note: OR, odds ratio; 95%CI, 95% confidence interval; FAST, functional assessment staging; GHPWD, group home for persons with dementia; ACP, advance care planning; ACP-PI, ACP Practice Inventory. * p < 0.05, ** p < 0.01, *** p < 0.001. Dependent variable: the QOD-LTC—0 = low, 1 = high. Regarding independent variables, relevant individual and facility attributes were entered in all models; for the ACP-PI, they were entered as follows: model 1: composite score; models 2–4: one for each factor; model 5: all for each factor. † 0 = male, 1 = female; ‡ 0 = less than 1 year, 1 = 1 year or more; § 0 = FAST level 6 or less, 1 = FAST level 7; ¶ 0 = none, 1 = with bonus. Factor 1: provision of information and conversation with the resident to encourage them to express their end-of-life wishes. Factor 2: preparations in case the resident becomes unable to express their own end-of-life wishes. Factor 3: devising to encourage the resident to express their wishes with consideration for their dementia.